Cargando…

Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma

Detalles Bibliográficos
Autores principales:	Lu, Congyi, Mahajan, Akanksha, Hong, Sung-Hyeok, Galli, Susana, Zhu, Shiya, Tilan, Jason U., Abualsaud, Nouran, Adnani, Mina, Chung, Stacey, Elmansy, Nada, Rodgers, Jasmine, Rodriguez, Olga, Albanese, Christopher, Wang, Hongkun, Regan, Maureen, Zgonc, Valerie, Blancato, Jan, Krawczyk, Ewa, Gallicano, G. Ian, Girgis, Michael, Cheema, Amrita, Iżycka-Świeszewska, Ewa, Cavalli, Luciane R., Pack, Svetlana D., Kitlinska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098441/ https://www.ncbi.nlm.nih.gov/pubmed/35550518 http://dx.doi.org/10.1038/s41467-022-30473-7

Ejemplares similares

Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma
por: Lu, Congyi, et al.
Publicado: (2022)

Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation
por: Abualsaud, Nouran, et al.
Publicado: (2021)

Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
por: Czarnecka, Magdalena, et al.
Publicado: (2014)

High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases
por: Hong, Sung-Hyeok, et al.
Publicado: (2015)

Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects
por: Tilan, Jason U., et al.
Publicado: (2013)

Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread
por: Sigorski, Dawid, et al.
Publicado: (2022)

Neuropeptide Y and its Y2 Receptor – Potential Targets in Neuroblastoma Therapy
por: Lu, Congyi, et al.
Publicado: (2010)

Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System
por: Han, Ruijun, et al.
Publicado: (2012)

Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
por: Sigorski, Dawid, et al.
Publicado: (2020)

Sympathetic Neurotransmitters and Tumor Angiogenesis—Link between Stress and Cancer Progression
por: Tilan, Jason, et al.
Publicado: (2010)

Hypoxic hepatitis as a complication of newly diagnosed type 1 diabetes in a teenager
por: Buczkowski, Kamil, et al.
Publicado: (2022)

Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors
por: Sigorski, Dawid, et al.
Publicado: (2021)

Association of Hepcidin mRNA Expression With Hepatocyte Iron Accumulation and Effects of Antiviral Therapy in Chronic Hepatitis C Infection
por: Sikorska, Katarzyna, et al.
Publicado: (2014)

High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor
por: Krawczyk, Malgorzata A., et al.
Publicado: (2021)

Primary Spinal Intradural Mesenchymal Chondrosarcoma with Several Local Regrowths Treated with Osteoplastic Laminotomies: A Case Report
por: Derenda, Marek, et al.
Publicado: (2017)

Sympathetic nervous signaling dictates prostate cancer progression
por: Sigorski, D., et al.
Publicado: (2022)

Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study
por: Nowicki, Tomasz K., et al.
Publicado: (2018)

Neuropeptide Y protocols /
Publicado: (2000)

Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
por: Izycka-Swieszewska, Ewa, et al.
Publicado: (2018)

Dysgerminoma with a Somatic Exon 17 KIT Mutation and SHH Pathway Activation in a Girl with Turner Syndrome
por: Gawrychowska, Ada, et al.
Publicado: (2020)

Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases
por: Bien, Ewa, et al.
Publicado: (2010)

Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?
por: Szurowska, Edyta, et al.
Publicado: (2011)

On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma
por: Lipska, Beata S, et al.
Publicado: (2013)

Preclinical Models of Neuroblastoma—Current Status and Perspectives
por: Krawczyk, Ewa, et al.
Publicado: (2023)

Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y
por: Comeras, Lucas B., et al.
Publicado: (2019)

Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo
por: Krawczyk, Ewa, et al.
Publicado: (2019)

Bilateral Ovarian Germ Cell Tumor in a 46,XX Female with Nijmegen Breakage Syndrome and Hypergonadotropic Hypogonadism
por: Krawczyk, Malgorzata A., et al.
Publicado: (2022)

The Role of Neuropeptide Y in the Nucleus Accumbens
por: Tanaka, Masaki, et al.
Publicado: (2021)

Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia/Reperfusion: View from the Perspective of the Laboratory Bench
por: Przykaza, Łukasz, et al.
Publicado: (2021)

Comparative genomic analysis of intracranial germ cell tumors – the preliminary study focused on Sonic Hedgehog signaling pathway
por: Kuleszo, Dominika, et al.
Publicado: (2017)

Expression of BARD1 β Isoform in Selected Pediatric Tumors
por: Jasiak, Anna, et al.
Publicado: (2021)

Case Report: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Application in Intraperitoneally Disseminated Inflammatory Myofibroblastic Tumor and in the Youngest Patient in the World: New Indication and Modification of Technique
por: Garnier, Hanna, et al.
Publicado: (2021)

Neuropeptide Y: Biomarker and intervention for surgical recovery
por: Zhao, Dong Fang, et al.
Publicado: (2015)

The fat regulator neuropeptide Y and caloric restriction
por: Park, Seongjoon, et al.
Publicado: (2017)

The Role of Neuropeptide Y in Cardiovascular Health and Disease
por: Tan, Cheryl M. J., et al.
Publicado: (2018)

Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
por: Li, Chunrong, et al.
Publicado: (2019)

Neuropeptide Y in Alcohol Addiction and Affective Disorders
por: Thorsell, Annika, et al.
Publicado: (2017)

Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect
por: Chen, Wei-can, et al.
Publicado: (2020)

Structural basis for ligand recognition of the neuropeptide Y Y(2) receptor
por: Tang, Tingting, et al.
Publicado: (2021)

Structural basis of neuropeptide Y signaling through Y1 receptor
por: Park, Chaehee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t56o7t2tbak11if5mfpv1dpnm6